our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 11 May 2015

    Antares Pharma Announces Closing of Public Offering of Common Stock
  • 11 May 2015

    Antares Pharma Reports First Quarter 2015 Financial and Operating Results
  • 6 May 2015

    Antares Pharma to Present at the Bank of America Merrill Lynch Healthcare Conference
  • 6 May 2015

    Antares Pharma Announces Pricing of Public Offering of Common Stock
  • 5 May 2015

    Antares Pharma to Host First Quarter 2015 Operating and Financial Results Call
  • 5 May 2015

    Antares Pharma Announces Proposed Public Offering of Common Stock

latest products & technology

 

Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>